Literature DB >> 19832910

Increased salivary lipid peroxidation in human subjects with oral lichen planus.

F Agha-Hosseini1, I Mirzaii-Dizgah, S Mikaili, M Abdollahi.   

Abstract

BACKGROUND: Oral lichen planus (OLP) is a chronic inflammatory mucosal disease of unknown aetiology. Recently, increased oxidative stress has been implicated in the pathogenesis of various diseases. The aim of this study was to evaluate the total antioxidant capacity (TAC) and lipid peroxidation level, in the saliva of patients with OLP.
METHOD: Thirty patients with OLP (15 men, 15 women; mean age 44.0, SD +/- 11.4 years) and 30 control subjects (16 men, 14 women; aged 23-67 years), matched for age and gender, were enrolled in this case and control study. This study was conducted at the Clinic of Oral Medicine of Tehran University of Medical Sciences in 2007. The unstimulated whole saliva malondialdehyde (MDA), as an indicator of lipid peroxidation and TAC levels were assayed by thiobarbituric acid and ferric reducing antioxidant potential (FRAP), respectively, in both groups.
RESULTS: Mean levels of saliva MDA, but not TAC, in patients with OLP was significantly higher than those of the control group.
CONCLUSION: We conclude that OLP patients have more cellular lipid peroxidation than healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19832910     DOI: 10.1111/j.1601-5037.2009.00365.x

Source DB:  PubMed          Journal:  Int J Dent Hyg        ISSN: 1601-5029            Impact factor:   2.477


  16 in total

1.  Identifying the association between interleukin-6 and lichen planus: A meta-analysis.

Authors:  Meng Yin; Guifeng Li; Hui Song; Song Lin
Journal:  Biomed Rep       Date:  2017-04-07

2.  Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.

Authors:  Jasdeep Kaur; Constantinus Politis; Reinhilde Jacobs
Journal:  Clin Oral Investig       Date:  2015-06-17       Impact factor: 3.573

Review 3.  Black pepper and its bioactive constituent piperine: promising therapeutic strategies for oral lichen planus.

Authors:  Jing-Ya Yang; Jing Zhang; Gang Zhou
Journal:  Inflammopharmacology       Date:  2018-10-20       Impact factor: 4.473

4.  Serum and saliva collagenase-3 (MMP-13) in patients with oral lichen planus and oral squamous cell carcinoma.

Authors:  Farzaneh Agha-Hosseini; Iraj Mirzaii-Dizgah
Journal:  Med J Islam Repub Iran       Date:  2015-06-07

5.  Salivary total antioxidant capacity and lipid peroxidation in patients with erosive oral lichen planus.

Authors:  Atena Shirzad; Mahdi Pouramir; Maryam Seyedmajidi; Niloofar Jenabian; Ali Bijani; Mina Motallebnejad
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2014-03-05

6.  Evaluation of Plasma Isoprostane in Patients with Oral Lichen Planus.

Authors:  Maryam Amirchaghmaghi; Seyed Isaac Hashemy; Banafsheh Alirezaei; Fereshteh Jahed Keyhani; Sanaz Kargozar; Samaneh Vasigh; Shideh Gharaei; Atessa Pakfetrat
Journal:  J Dent (Shiraz)       Date:  2016-03

Review 7.  Salivary and Urinary Total Antioxidant Capacity as Biomarkers of Oxidative Stress in Humans.

Authors:  Ilaria Peluso; Anna Raguzzini
Journal:  Patholog Res Int       Date:  2016-02-07

8.  Evaluation of saliva glutathione, glutathione peroxidase, and malondialdehyde levels in head-neck radiotherapy patients

Authors:  Gözde Derindağ; Hayati Murat Akgül; Ahmet Kızıltunç; Halil İbrahim Özkan; Hilal Kızıltunç Özmen; Nilgün Akgül
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

9.  Evaluation of serum nitric oxide level in patients with oral lichen planus.

Authors:  M Mehdipour; A Taghavi Zenouz; A Bahramian; N Gholizadeh; M Boorghani
Journal:  J Dent (Shiraz)       Date:  2014-06

10.  Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals.

Authors:  Hamidreza Abdolsamadi; Nasrin Rafieian; Mohammad Taghi Goodarzi; Javad Feradmal; Poorandokht Davoodi; Mina Jazayeri; Zahrasadat Taghavi; Seyed-Mostafa Hoseyni; Fatemeh Ahmadi-Motamayel
Journal:  Chonnam Med J       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.